NYSE:CVS - New York Stock Exchange, Inc. - US1266501006 - Common Stock - Currency: USD
67.29
-1.26 (-1.84%)
The current stock price of CVS is 67.29 USD. In the past month the price decreased by -1.97%. In the past year, price decreased by -3.53%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.07 | 89.50B | ||
DGX | QUEST DIAGNOSTICS INC | 18.16 | 18.18B | ||
LH | LABCORP HOLDINGS INC | 14.9 | 18.17B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.78 | 13.88B | ||
DVA | DAVITA INC | 14.74 | 11.20B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.15 | 10.60B | ||
CHE | CHEMED CORP | 25.14 | 8.50B | ||
HIMS | HIMS & HERS HEALTH INC | 50.43 | 6.05B | ||
CRVL | CORVEL CORP | 27.53 | 5.91B | ||
GH | GUARDANT HEALTH INC | N/A | 5.55B | ||
OPCH | OPTION CARE HEALTH INC | 26.25 | 5.26B | ||
RDNT | RADNET INC | 79.02 | 3.69B |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
CVS HEALTH CORP
1 Cvs Dr
Woonsocket RHODE ISLAND 02895 US
CEO: Karen S. Lynch
Employees: 259500
Company Website: https://cvshealth.com/
Investor Relations: https://investors.cvshealth.com
Phone: 14017651500
The current stock price of CVS is 67.29 USD. The price decreased by -1.84% in the last trading session.
The exchange symbol of CVS HEALTH CORP is CVS and it is listed on the New York Stock Exchange, Inc. exchange.
CVS stock is listed on the New York Stock Exchange, Inc. exchange.
33 analysts have analysed CVS and the average price target is 72.4 USD. This implies a price increase of 7.59% is expected in the next year compared to the current price of 67.29. Check the CVS HEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CVS HEALTH CORP (CVS) has a market capitalization of 84.95B USD. This makes CVS a Large Cap stock.
CVS HEALTH CORP (CVS) currently has 259500 employees.
CVS HEALTH CORP (CVS) has a support level at 66.39 and a resistance level at 69.51. Check the full technical report for a detailed analysis of CVS support and resistance levels.
The Revenue of CVS HEALTH CORP (CVS) is expected to grow by 4.67% in the next year. Check the estimates tab for more information on the CVS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CVS HEALTH CORP (CVS) has a dividend yield of 3.86%. The yearly dividend amount is currently 2.65. Check the full fundamental report for a detailed analysis of CVS dividend history, reliability and sustainability.
CVS HEALTH CORP (CVS) will report earnings on 2025-05-01, before the market open.
The PE ratio for CVS HEALTH CORP (CVS) is 12.42. This is based on the reported non-GAAP earnings per share of 5.42 and the current share price of 67.29 USD. Check the full fundamental report for a full analysis of the valuation metrics for CVS.
The outstanding short interest for CVS HEALTH CORP (CVS) is 1.64% of its float. Check the ownership tab for more information on the CVS short interest.
ChartMill assigns a technical rating of 7 / 10 to CVS. When comparing the yearly performance of all stocks, CVS is one of the better performing stocks in the market, outperforming 88.05% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CVS. While CVS is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months CVS reported a non-GAAP Earnings per Share(EPS) of 5.42. The EPS decreased by -37.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.24% | ||
ROA | 1.82% | ||
ROE | 6.11% | ||
Debt/Equity | 0.83 |
ChartMill assigns a Buy % Consensus number of 76% to CVS. The Buy consensus is the average rating of analysts ratings from 33 analysts.
For the next year, analysts expect an EPS growth of 10.01% and a revenue growth 4.67% for CVS